Literature DB >> 467210

Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy.

G Marchesini, G Forlani, M Zoli, A Angiolini, M P Scolari, F B Bianchi, E Pisi.   

Abstract

Alterations in insulin and glucagon levels might account for the plasma amino acid imbalance of cirrhotics. In order to verify this hypothesis we evaluated basal insulin, glucagon, branched-chain amino acids, aromatic amino acids, and free tryptophan in 13 controls and 37 cirrhotics divided on the basis of their mental state; in 4 patients the hormonal and amino acid patterns were sequentially studied during various stages of encephalopathy. Glucagon is high in cirrhotics and progressively increases with the worsening of the mental state. Free tryptophan and aromatic amino acids show a similar behavior and significantly correlate with glucagon levels (r = 0.67 and r = 0.81, respectively). On the other hand insulin levels, which are high in cirrhotics without encephalopathy, fall in the presence of deep coma. Insulin did not correlate with any of the plasma amino acids considered. Our data suggest that the catabolic state associated with increased glucagon levels may account for some of the alterations in the plasma amino acid profiles of cirrhotics. Portal-systemic shunting does not seem to be the common cause of both hyperglucagonemia and hyperaminoacidemia. Decreased branched-chain amino acid levels may be related to factors different from those involved in the alterations of carbohydrate homeostasis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467210     DOI: 10.1007/bf01333703

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Metabolism of forearm tissues in man. Studies with glucagon.

Authors:  T Pozefsky; R G Tancredi; R T Moxley; J Dupre; J D Tobin
Journal:  Diabetes       Date:  1976-02       Impact factor: 9.461

2.  Insulin, glucagon, portal systemic shunting, and hepatic failure in the dog.

Authors:  P B Soeters; G Weir; A M Ebeid; J E Fischer
Journal:  J Surg Res       Date:  1977-09       Impact factor: 2.192

3.  Effects of glucagon on general protein degradation and synthesis in perfused rat liver.

Authors:  K H Woodside; W F Ward; G E Mortimore
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

4.  Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.

Authors:  K C Lam; A R Tall; G B Goldstein; S P Mistilis
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Glucose intolerance and insulin resistance in patients with liver disease.

Authors:  J R Collins; O B Crofford
Journal:  Arch Intern Med       Date:  1969-08

Review 6.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

7.  Tryptophan and hepatic coma.

Authors:  J Ono; D G Hutson; R S Dombro; J U Levi; A Livingstone; R Zeppa
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

9.  Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.

Authors:  G Marchesini; G Forlani; A Angiolini; M Zoli; M P Scolari; F B Bianchi; E Pisi
Journal:  Diabete Metab       Date:  1979-06

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  12 in total

1.  Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Authors:  N Tanabe; M Ishii; Y Sato; T Akahane; N Kobayashi; H Gama; T Iwasaki; T Toyota
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 2.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

3.  The presence of glucagon in ascitic fluid in cirrhotic patients.

Authors:  U M Kabadi; M S Uddinn; A B Eisenstein
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

4.  Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance.

Authors:  G Marchesini; M Zoli; C Dondi; L Cecchini; A Angiolini; F B Bianchi; E Pisi
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

5.  Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

Authors:  G Marchesini; M Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

Review 6.  Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.

Authors:  Gitte Dam; Peter Ott; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2013-01-15       Impact factor: 3.584

7.  Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.

Authors:  B Limberg; B Kommerell
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

8.  Pancreatic hormones and amino acid levels following liver transplantation.

Authors:  A Francavilla; L Polimeno; D H Van Thiel; S Todo; I Kam; S Lynch; T E Starzl
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

9.  Relationship of plasma amino acids to nitrogen balance and portal-systemic encephalopathy in alcoholic liver disease.

Authors:  F L Weber; B J Reiser
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

10.  Plasma amino-acid patterns in liver disease.

Authors:  M Y Morgan; A W Marshall; J P Milsom; S Sherlock
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.